Bal Pharma Limited Working Capital to Net Assets Ratio
Bal Pharma Limited working capital to net assets ratio. Bal Pharma Limited (BALPHARMA) has a Working Capital to Net Assets ratio of 15.8% as of March 2026. Working capital of Rs130.06 Million (current assets of Rs2.62 Billion minus current liabilities of Rs2.49 Billion) is measured against net assets of Rs822.52 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check tangible net worth ratio of Bal Pharma Limited to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Bal Pharma Limited (2006–2026)
Working capital to net assets ratio of Bal Pharma Limited from 2006 to 2026. This chart shows how Bal Pharma Limited's Working Capital to Net Assets ratio has evolved across 21 annual periods from 2006 to 2026. As of March 2026, the ratio stands at 15.8%, reflecting working capital of Rs130.06 Million against net assets of Rs822.52 Million INR. See Bal Pharma Limited defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Bal Pharma Limited Working Capital to Net Assets Ratio by Year (2006–2026)
Bal Pharma Limited working capital to net assets ratio by year from 2006 to 2026. The table below presents the year-by-year Working Capital to Net Assets ratio for Bal Pharma Limited from 2006 to 2026, covering 21 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see BALPHARMA total asset value.
| Year | WC/NA Ratio | Working Capital (INR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2026 | 15.8% | Rs130.06 Million | Rs822.52 Million | Rs2.62 Billion | Rs2.49 Billion | ▼ -4.0 pp |
| 2025 | 19.9% | Rs153.72 Million | Rs774.04 Million | Rs2.35 Billion | Rs2.20 Billion | ▼ -25.0 pp |
| 2024 | 44.9% | Rs311.04 Million | Rs692.61 Million | Rs2.34 Billion | Rs2.03 Billion | ▲ +15.4 pp |
| 2023 | 29.5% | Rs188.22 Million | Rs637.02 Million | Rs2.28 Billion | Rs2.09 Billion | ▼ -2.8 pp |
| 2022 | 32.4% | Rs189.26 Million | Rs584.92 Million | Rs1.85 Billion | Rs1.66 Billion | ▲ +10.6 pp |
| 2021 | 21.8% | Rs116.14 Million | Rs533.54 Million | Rs1.64 Billion | Rs1.53 Billion | ▲ +18.2 pp |
| 2020 | 3.6% | Rs16.38 Million | Rs453.38 Million | Rs1.61 Billion | Rs1.59 Billion | ▼ -27.4 pp |
| 2019 | 31.0% | Rs186.69 Million | Rs602.21 Million | Rs1.82 Billion | Rs1.63 Billion | ▼ -20.1 pp |
| 2018 | 51.1% | Rs307.35 Million | Rs602.01 Million | Rs1.76 Billion | Rs1.45 Billion | ▼ -15.5 pp |
| 2017 | 66.5% | Rs399.37 Million | Rs600.31 Million | Rs1.61 Billion | Rs1.21 Billion | ▲ +8.4 pp |
| 2016 | 58.1% | Rs318.06 Million | Rs547.22 Million | Rs1.43 Billion | Rs1.11 Billion | ▲ +35.0 pp |
| 2015 | 23.1% | Rs127.66 Million | Rs551.68 Million | Rs1.05 Billion | Rs923.58 Million | ▲ +6.5 pp |
| 2014 | 16.7% | Rs83.45 Million | Rs500.50 Million | Rs951.17 Million | Rs867.72 Million | ▲ +15.4 pp |
| 2013 | 1.2% | Rs5.48 Million | Rs446.18 Million | Rs932.14 Million | Rs926.66 Million | ▲ +5.8 pp |
| 2012 | -4.5% | Rs-18.21 Million | Rs400.56 Million | Rs844.97 Million | Rs863.18 Million | ▼ -132.6 pp |
| 2011 | 128.0% | Rs463.12 Million | Rs361.75 Million | Rs809.00 Million | Rs345.88 Million | ▲ +12.2 pp |
| 2010 | 115.8% | Rs414.20 Million | Rs357.62 Million | Rs692.04 Million | Rs277.84 Million | ▲ +35.5 pp |
| 2009 | 80.3% | Rs299.08 Million | Rs372.35 Million | Rs612.54 Million | Rs313.46 Million | ▼ -18.4 pp |
| 2008 | 98.8% | Rs346.01 Million | Rs350.32 Million | Rs582.65 Million | Rs236.64 Million | ▲ +48.7 pp |
| 2007 | 50.1% | Rs167.21 Million | Rs334.02 Million | Rs548.08 Million | Rs380.87 Million | ▼ -5.3 pp |
| 2006 | 55.3% | Rs178.73 Million | Rs323.02 Million | Rs589.65 Million | Rs410.91 Million | — |